Sanofi
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
(0.0% 1d) (-4.1% 1m) (-17.9% 1y) (0.0% 2d) (0.0% 3d) (-0.2% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 119,207,711,119
http://www.sanofi.com
Sec Filling | Patents | 100409 employees
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
vaccine cardiovascular diabetes diabetic
add to watch list Paper trade email alert is off
Press-releases
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Published: 2024-04-23 (Crawled : 05:00) - globenewswire.com
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
study
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
Published: 2024-04-22 (Crawled : 22:00) - globenewswire.com
REGN | News | $899.71 0.32% 0.32% 340K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
genetic cell research therapy
Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 22:00) - prnewswire.com
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.59 2.11% -0.36% 3.8M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
| Email alert
Add to watchlist
RBGLY | News | $10.35 -2.05% 500K
|
Manufacturing
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $136.2 -4.19% 1.7K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
RBGPF | News | $51.75 6.46% 3.6K
|
Consumer Non-Durables
| Email alert
Add to watchlist
drug astrazeneca set key therapeutics market
23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer
Published: 2024-04-22 (Crawled : 05:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
pharma cancer for
AbbVie Tops Doctor Ranking of Immunology Companies, Handily Beating Pfizer and J&J
Published: 2024-04-22 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.41%
H: 1.19%
C: 0.41%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
abbvie immunology
Biopharma Layoff Tracker 2024: Sanofi, Vedanta, Fujifilm and More Cut Staff
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
RLYB | News | $1.79 1.7% 1.68% 270K
|
|
| O: 1.14%
H: 3.37%
C: -0.56%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.41%
H: 1.19%
C: 0.41%
VXRT | News | $0.7625 0.91% 0.9% 940K
|
Health Technology
|
| O: 2.63%
H: 2.56%
C: -2.56%
TXMD | News | $1.88 1.08% 1.06% 19K
|
Health Technology
|
| O: 0.54%
H: 3.21%
C: 0.53%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
PTCT | News S | $25.96 2.53% 2.47% 650K
|
Health Technology
|
| O: 0.08%
H: 4.54%
C: 2.49%
NKTR | News | $1.37 10.48% 9.49% 2M
|
Health Technology
|
| O: 5.65%
H: 7.63%
C: 3.82%
MOR | News | $17.97 -0.06% -0.06% 330K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
GLPG | News | $29.09 0.03% -0.14% 80K
|
Health Technology
|
| O: -0.41%
H: 1.52%
C: 0.38%
AMRN | News | $0.8648 0.64% 0.64% 740K
|
Health Technology
|
| O: -2.31%
H: 2.33%
C: 1.16%
GOOGL | News S | $156.3 1.43% 1.41% 26M
|
Technology Services
|
| O: 0.14%
H: 2.16%
C: 1.28%
GOOG | News S | $157.96 1.44% 1.42% 15M
|
Technology Services
|
| O: 0.19%
H: 2.04%
C: 1.24%
OCX | News | $2.51 0.4% 0.4% 63K
|
Health Technology
|
| O: 0.8%
H: 1.59%
C: -0.4%
biopharma
Biopharma Layoff Tracker 2024: Pfizer, Sanofi, Vedanta and More Cut Staff
Published: 2024-04-22 (Crawled : 16:00) - biospace.com/
AMRN | News | $0.8648 0.64% 0.64% 740K
|
Health Technology
|
| O: -2.31%
H: 2.33%
C: 1.16%
GOOGL | News S | $156.3 1.43% 1.41% 26M
|
Technology Services
|
| O: 0.14%
H: 2.16%
C: 1.28%
GOOG | News S | $157.96 1.44% 1.42% 15M
|
Technology Services
|
| O: 0.19%
H: 2.04%
C: 1.24%
OCX | News | $2.51 0.4% 0.4% 63K
|
Health Technology
|
| O: 0.8%
H: 1.59%
C: -0.4%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.41%
H: 1.19%
C: 0.41%
VXRT | News | $0.7625 0.91% 0.9% 940K
|
Health Technology
|
| O: 2.63%
H: 2.56%
C: -2.56%
TXMD | News | $1.88 1.08% 1.06% 19K
|
Health Technology
|
| O: 0.54%
H: 3.21%
C: 0.53%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: 0.0%
PTCT | News S | $25.96 2.53% 2.47% 650K
|
Health Technology
|
| O: 0.08%
H: 4.54%
C: 2.49%
NKTR | News | $1.37 10.48% 9.49% 2M
|
Health Technology
|
| O: 5.65%
H: 7.63%
C: 3.82%
MOR | News | $17.97 -0.06% -0.06% 330K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
GLPG | News | $29.09 0.03% -0.14% 80K
|
Health Technology
|
| O: -0.41%
H: 1.52%
C: 0.38%
RLYB | News | $1.79 1.7% 1.68% 270K
|
|
| O: 1.14%
H: 3.37%
C: -0.56%
biopharma
Progressive Familial Intrahepatic Cholestasis Treatment Market Projected to Reach $156.14 million by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 02:00) - prnewswire.com
TAK | News | $13.36 0.91% -0.52% 1.6M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
MIRM | $24.17 1.51% 1.49% 250K
|
Health Technology
|
| O: -0.68%
H: 2.52%
C: 1.71%
report million reach treatment market
Sanofi Cuts Jobs in U.S. Vaccines Division as Part of Restructuring
Published: 2024-04-19 (Crawled : 12:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
sanofi
J&J, Other Q1 Financials Beg the Queston: What Does It Mean to Miss Expectations?
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
miss
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Last 48 Hours Insiders Buying
MCFT P 26039 | $21.5 1.9% 1.86% 110K
|
Consumer Durables
|
00:00
YORW P 29 | $35.43 1.03% 1.02% 66K
|
Utilities
|
19:01
VUZI P 14500 | $1.35 11.57% 10.37% 890K
|
Electronic Technology
|
17:00
BANF P 256 | $91.28 2.24% 2.18% 150K
|
Finance
|
15:30
RMCF | $3.56 0.28% 0.28% 11K
|
Consumer Non-Durables
|
20:10